Market Cap 1.49M
Revenue (ttm) 8.68M
Net Income (ttm) -11.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -131.22%
Debt to Equity Ratio 0.00
Volume 121,710,018
Avg Vol 6,570,620
Day's Range N/A - N/A
Shares Out 3.31M
Stochastic %K 46%
Beta 1.59
Analysts Hold
Price Target $1.00

Latest News on RSLS

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split

Sep 19, 2024, 8:31 AM EDT - 7 months ago

ReShape Lifesciences Announces 1-for-58 Reverse Stock Split


ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call Transcript

May 17, 2024, 8:57 PM EDT - 11 months ago

ReShape Lifesciences, Inc. (RSLS) Q1 2024 Earnings Call Transcript